Single Slide Assessment: the future of molecular testing in lung cancer?
Conclusions: SSA is highly effective at preserving samples for molecular testing from EBUS-FNA. Therefore a single minimally invasive procedure offers access to novel immunotherapy, enhancing lung cancer care. With increasing emphasis on immunotherapy its value is likely to increase.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Diggins, B., Glinski, L., Garvican, J., Wijesinghe, M. Tags: Lung Cancer Source Type: research
More News: Adenocarcinoma | Bronchoscopy | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Fine Needle Aspiration | Immunotherapy | Lung Cancer | Lymphoma | Respiratory Medicine | Squamous Cell Carcinoma | Ultrasound